These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

772 related items for PubMed ID: 16138944

  • 1. Novolizer: how does it fit into inhalation therapy?
    Magnussen H.
    Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
    [Abstract] [Full Text] [Related]

  • 2. Key issues in inhalation therapy in children.
    Brand PL.
    Curr Med Res Opin; 2005; 21 Suppl 4():S27-32. PubMed ID: 16138942
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Successful use of DPI systems in asthmatic patients--key parameters.
    Richter K.
    Respir Med; 2004 Oct; 98 Suppl B():S22-7. PubMed ID: 15481285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW.
    Int J Pharm; 2006 Mar 09; 310(1-2):81-9. PubMed ID: 16442246
    [Abstract] [Full Text] [Related]

  • 12. [The efficacy of Turbuhaler dry powder inhaler in Japanese asthma--measurement of peak inspiratory flow when using Turbuhaler].
    Kaneko N, Narushima M, Tanaka K, Suzuki H.
    Arerugi; 1996 Jul 09; 45(7):649-54. PubMed ID: 8831169
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Achieving asthma control.
    Barnes PJ.
    Curr Med Res Opin; 2005 Jul 09; 21 Suppl 4():S5-9. PubMed ID: 16138939
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.
    Health Technol Assess; 2001 Jul 09; 5(26):1-149. PubMed ID: 11701099
    [Abstract] [Full Text] [Related]

  • 17. Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers.
    Munzel U, Marschall K, Fyrnys B, Wedel M.
    Curr Med Res Opin; 2005 Jun 09; 21(6):827-33. PubMed ID: 15969882
    [Abstract] [Full Text] [Related]

  • 18. Improvement of asthma therapy by a novel budesonide multidose dry powder inhaler.
    Möller M, Fritsche D, Rivera D, Libertus H.
    Arzneimittelforschung; 2003 Jun 09; 53(8):562-7. PubMed ID: 13677246
    [Abstract] [Full Text] [Related]

  • 19. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
    Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment.
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov 12; 46(11):1055-1067. PubMed ID: 37914418
    [Abstract] [Full Text] [Related]

  • 20. How to achieve good compliance with inhaled asthma therapy.
    Crompton GK.
    Respir Med; 2004 Oct 12; 98 Suppl B():S35-40. PubMed ID: 15481287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.